GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
51.30
+0.26 (+0.51%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close51.04
Open51.25
Bid0.00 x 1100
Ask51.30 x 3100
Day's Range50.90 - 51.75
52 Week Range38.01 - 57.83
Volume384,490
Avg. Volume600,523
Market Cap5.083B
Beta (3Y Monthly)1.01
PE Ratio (TTM)36.64
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire

    Globus Medical Reports Second Quarter 2019 Results

    AUDUBON, Pa., Aug. 01, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended.

  • GlobeNewswire

    Globus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call

    AUDUBON, Pa., July 15, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended.

  • GlobeNewswire

    Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the appointment of Keith W. Pfeil as its Senior Vice President and Chief Financial Officer effective August 19, 2019. Mr. Pfeil joins Globus Medical after almost 16 years at CSS Industries, a publicly traded consumer products company, in which he served in a number of financial leadership roles, most recently as Executive Vice President and Chief Financial Officer. Mr. Pfeil’s financial leadership experience includes experience with Financial Planning and Analysis, Internal Audit and Investor Relations.

  • GlobeNewswire

    Globus Medical Launches First Expandable Interspinous Fixation – AERIAL™

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of AERIAL™, a minimally invasive expandable interspinous fixation system with independent locking plates. This is Globus Medical’s first expandable interspinous fixation system, adding to their industry leading expandable technology portfolio. Dr. David Bomback, an orthopedic surgeon and partner at Connecticut Neck and Back Specialists, and Dr. Sumit Das, founder and neurosurgeon with Brain and Spine Neurosurgical Institute, recently performed the first AERIAL™ procedures at Danbury Hospital, Danbury, Connecticut, and Our Lady of Fatima Hospital, North Providence, Rhode Island, respectively.

  • GlobeNewswire

    New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®

    Globus Medical (GMED), a leading musculoskeletal solutions company today announced the results of a clinical study that evaluated the versatility of ExcelsiusGPS® Robotic navigation system compared to traditional pedicle screw placement techniques. Published in the Journal of Robotic Surgery, “Robotic-assisted navigated minimally invasive pedicle screw placement in the first 100 cases at a single institution,” demonstrated a 99% screw placement success rate with no malpositions or postoperative returns to the O.R. related to screw placement. The study explored how the ExcelsiusGPS® advanced navigated robotic technology combines the ability to use three imaging workflows (preoperative CT, intraoperative CT, and fluoroscopy) with navigation and guidance to accurately place pedicle screws with real-time feedback.

  • GlobeNewswire

    Globus Medical Reports First Quarter 2019 Results

    AUDUBON, Pa., May 02, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended.

  • GlobeNewswire

    Globus Medical Schedules First Quarter 2019 Earnings Release and Conference Call

    AUDUBON, Pa., April 17, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended.

  • GlobeNewswire

    Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of FORTIFY VA™, a variable angle corpectomy solution, to add to its large and growing Expandable Technology portfolio.  Globus Medical is the industry leader in expandable technology with over 20 expandable implant options backed by 15 years of engineering, testing, and clinical experience.  The company’s Expandable Technology portfolio consists of the most innovative devices on the market, designed to improve clinical results using minimally invasive surgery (MIS) approaches. Building on Globus Medical’s experience and innovation, FORTIFY VA™ is an expandable corpectomy spacer designed to optimize anatomical fit using an anterior cervical approach or one of several approaches to the thoracolumbar spine.

  • GlobeNewswire

    Globus Medical Reports Full Year and Fourth Quarter 2018 Results

    AUDUBON, Pa., Feb. 21, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and.

  • GlobeNewswire

    Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call

    AUDUBON, Pa., Feb. 05, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and.

  • GlobeNewswire

    Report: Developing Opportunities within Hyatt Hotels, Carter's, Globus Medical, Switch, Prothena Corporation plc, and Assurant — Future Expectations, Projections Moving into 2019

    NEW YORK, Jan. 30, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • GlobeNewswire

    Globus Medical’s SECURE®C Cervical Artificial Disc Receives Expanded Insurance Coverage

    A long term, seven-year clinical trial follow-up study published in the prominent International Journal of Spine Surgery demonstrated the superiority of SECURE-C® in terms of overall success, compared to Anterior Cervical Discectomy and Fusion (ACDF), the current standard of care for cervical disc disease. The SECURE-C® Cervical Artificial Disc is implanted using an anterior approach.

  • ACCESSWIRE

    The Most Innovative Healthcare AI Developments of 2019

    HOUSTON, TX / ACCESSWIRE / January 9, 2019 / Technology has changed in the blink of an eye. Concepts that were nothing more than science fiction, such as artificial intelligence (AI) and machine learning are now quickly disrupting global industries with significant capabilities. In fact, the limitless potential of AI alone is disrupting businesses, the way we conduct our affairs, and even the way financial institutions conduct high-frequency trading.

  • GlobeNewswire

    Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2018. The company anticipates fourth quarter 2018 sales of approximately $195.5 million, an increase of 11.0% over the fourth quarter 2017. “Our fourth quarter and full year results are indicative of strong momentum in several key strategic areas,” said Dave Demski, CEO.

  • ACCESSWIRE

    Today's Research Reports on Trending Tickers: Edwards Lifesciences and Globus Medical

    NEW YORK, NY / ACCESSWIRE / December 7, 2018 / U.S. equities finished modestly lower on Thursday as trade concerns were reignited after the arrest of a Huawei senior executive. The Dow Jones Industrial ...

  • GlobeNewswire

    Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS®, a revolutionary robotic guidance and navigation system, to the international market with system installations completed in several European countries. This past October, the first European Excelsius GPS® procedure was performed at the Metropolitan Hospital in Neo Faliro, Athens, Greece by Mr. Panagiotis E. Zoumpoulis. Since then, numerous open and minimally invasive spine procedures have been performed at Bonifatius Hospital in Germany and at the Fornaca Clinic in Italy.

  • GlobeNewswire

    Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire

    Globus Medical Reports Third Quarter 2018 Results

    AUDUBON, Pa., Nov. 08, 2018 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended.